Patrick H van Berkel

4PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 28, 2026
Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody-Drug Conjugate against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

|Oct 07, 2026
Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody-Drug Conjugate Against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

|May 22, 2024
Selective haematological cancer eradication with preserved haematopoiesis.

Simon Garaudé, Romina Marone, Rosalba Lepore

|Feb 07, 2024
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies.

Francesca Zammarchi, Karin E Havenith, Nikoleta Sachini

Pageof 1

Frequent Collaborators

3 joint publications

Narinder Janghra

2 joint publications

Danilo Cucchi

2 joint publications

Alison Faid

2 joint publications

Rebecca Martin